The epidemiology of drug-related hospital admissions in paediatrics – a systematic review

Sonja Eberl*, Pauline Heus, Irmgard Toni, Igor Bachmat, Antje Neubert

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Background: Despite previous efforts, medication safety in paediatrics remains a major concern. To inform improvement strategies and further research especially in outpatient care, we systematically reviewed the literature on the frequency and nature of drug-related hospital admissions in children. Methods: Searches covered Embase, Medline, Web of Science, grey literature sources and relevant article citations. Studies reporting epidemiological data on paediatric drug-related hospital admissions published between 01/2000 and 01/2024 were eligible. Study identification, data extraction, and critical appraisal were conducted independently in duplicate using templates based on the ’Joanna Briggs Institute’ recommendations. Results: The review included data from 45 studies reporting > 24,000 hospitalisations for adverse drug events (ADEs) or adverse drug reactions (ADRs). Due to different reference groups, a total of 52 relative frequency values were provided. We stratified these results by study characteristics. As a percentage of inpatients, the highest frequency of drug-related hospitalisation was found with ‘intensive ADE monitoring’, ranging from 3.1% to 5.8% (5 values), whereas with ‘routine ADE monitoring’, it ranged from 0.2% to 1.0% (3 values). The relative frequencies of ‘ADR-related hospitalisations’ ranged from 0.2% to 6.9% for ‘intensive monitoring’ (23 values) and from 0.04% to 3.8% for ‘routine monitoring’ (8 values). Per emergency department visits, five relative frequency values ranged from 0.1% to 3.8% in studies with ‘intensive ADE monitoring’, while all other eight values were ≤ 0.1%. Heterogeneity prevented pooled estimates. Studies rarely reported on the nature of the problems, or studies with broader objectives lacked disaggregated data. Limited data indicated that one in three (median) drug-related admissions could have been prevented, especially by more attentive prescribing. Besides polypharmacy and oncological therapy, no other risk factors could be clearly identified. Insufficient information and a high risk of bias, especially in retrospective and routine observational studies, hampered the assessment. Conclusion: Given the high frequency of drug-related hospitalisations, medication safety in paediatrics needs to be further improved. As routine identification appears unreliable, clinical awareness needs to be raised. To gain more profound insights especially for generating improvement strategies, we have to address under-reporting and methodological issues in future research.

Original languageEnglish
Article number81
Number of pages16
JournalArchives of Public Health
Volume82
Issue number1
DOIs
Publication statusPublished - 4 Jun 2024

Keywords

  • Adverse drug events
  • Adverse drug reactions
  • Children
  • Drug-related hospitalisations
  • Drug-related problems
  • Hospital admissions
  • Hospitalisation
  • Medication safety
  • Paediatric

Fingerprint

Dive into the research topics of 'The epidemiology of drug-related hospital admissions in paediatrics – a systematic review'. Together they form a unique fingerprint.

Cite this